Deutsch English Français Italiano |
<d9kKDOBnQ1et-HSR2ecTM2R2Ziw@jntp> View for Bookmarking (what is this?) Look up another Usenet article |
Path: ...!3.eu.feeder.erje.net!feeder.erje.net!paganini.bofh.team!pasdenom.info!from-devjntp Message-ID: <d9kKDOBnQ1et-HSR2ecTM2R2Ziw@jntp> JNTP-Route: news2.nemoweb.net JNTP-DataType: Article Subject: Re: Vaccins Covid-19 et syndrome de =?UTF-8?Q?Guillain-Barr=C3=A9?= References: <Qkk737iQUUKOsXPoaVzasuytvxA@jntp> Newsgroups: fr.misc.actualite.covid19 JNTP-HashClient: VZiJZS46D-f5UUk4JkUmj6S5L74 JNTP-ThreadID: FacOVlu5KgL7dSjOn4vdVrOtvFM JNTP-ReferenceUserID: 2@news2.nemoweb.net JNTP-Uri: http://news2.nemoweb.net/?DataID=d9kKDOBnQ1et-HSR2ecTM2R2Ziw@jntp User-Agent: Nemo/0.999a JNTP-OriginServer: news2.nemoweb.net Date: Thu, 12 Oct 23 10:17:56 +0000 Organization: Nemoweb JNTP-Browser: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/110.0.0.0 Iron Safari/537.36 Injection-Info: news2.nemoweb.net; posting-host="43d157f9437411bd9c60ee58b39a513a2d9d2b85"; logging-data="2023-10-12T10:17:56Z/8294028"; posting-account="3@news2.nemoweb.net"; mail-complaints-to="newsmaster@news2.nemoweb.net" JNTP-ProtocolVersion: 0.21.1 JNTP-Server: PhpNemoServer/0.94.5 MIME-Version: 1.0 Content-Type: text/plain; charset=UTF-8; format=flowed Content-Transfer-Encoding: 8bit X-JNTP-JsonNewsGateway: 0.96 From: Eric M <conanospamic@gmail.com> Bytes: 2042 Lines: 14 Le 12/10/2023 à 09:01, Duzz' a écrit : > Les vaccins à ARNm n'augmentent pas le risque de syndrome de Guillain-Barré, > à la différence des vaccins à vecteur adénoviral : > > <https://ansm.sante.fr/actualites/les-vaccins-a-arnm-naugmentent-pas-le-risque-de-syndrome-de-guillain-barre-a-la-difference-des-vaccins-a-vecteur-adenoviral> > > Risk of Guillain-Barré Syndrome Following COVID-19 Vaccines : > <https://n.neurology.org/content/early/2023/10/03/WNL.0000000000207847> > > Publication EPI-PHARE : > > <https://ansm.sante.fr/uploads/2023/10/11/20231011-epi-phare-rapport-guillain-barre.pdf> Bizarrement, je sens qu'on ne va pas trop voir les antivax sur ce coup.